Overview

Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy

Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety and tolerability of oxymorphone ER as an analgesic in cancer and lower back pain subjects having chronic moderate to severe pain.
Phase:
Phase 3
Details
Lead Sponsor:
Endo Pharmaceuticals
Treatments:
Analgesics
Oxymorphone